Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.
Frequently asked questions
What sector does Medios AG (MEDOF) operate in?
Medios AG belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is Medios AG (MEDOF) current stock price?
As of the latest data, Medios AG stock price is $50.00, with a previous close of $50.00.
What is Medios AG (MEDOF) current market capitalization?
Medios AG market cap is approximately 1.28 billion.
What is Medios AG (MEDOF) Earnings Per Share (EPS)?
The trailing EPS is $0.68.
What is Medios AG (MEDOF) Price-to-Earnings (P/E) ratio?
Medios AG current P/E ratio is 73.53.
What is Medios AG (MEDOF) EBITDA?
Medios AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 21.93 million.
Does Medios AG (MEDOF) pay dividends?
No. Medios AG does not pay a dividend.
What is Medios AG (MEDOF) beta (volatility) score?
Medios AG has a beta of 1.296, suggesting it is more volatile than the market.
